Parenteral access medical devices supply
Original notice title
France – Medical consumables – UniHA_Fourniture de dispositifs médicaux de l’abord parentéral – PAR24 - M_2917
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
35 / 100
Risk factors
Inconsistency between structured data (isEuFunded=true) and XML notice (no-eu-funds). This may affect contract conditio...
Essential details such as exact eligibility criteria, award criteria, and required documents are missing, increasing bi...
Restricted procedure — pre-qualification required
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Tender facts
- Contracting authority
- GCS UniHA
- Country
- France
- CPV
- 33140000 - Medical consumables +7 more
- Deadline
- Apr 21, 2033
- Estimated value
- EUR 426.6M
Overview
Moderate opportunityKey Facts
- EUR 426.6M estimated value
- Dynamic Purchasing System (DPS)
- Supplies contract
- 1 lot
- Duration 120 MONTH
- Supply of medical devices for parenteral access
- Scope includes infusion supplies, syringes, catheters, medical needles, anesthesia needles, and related consumables
Show full summary
This tender is a Dynamic Purchasing System (DPS) for the supply of medical devices for parenteral access (dispositifs médicaux de l'abord parentéral) to member institutions of GCS UniHA. The DPS has a single lot with an estimated value of EUR 426,593,580 over 120 months. The procedure is restricted, and candidatures are selected based on economic, financial, and professional capacity criteria (article 7.2 of the RC). The DPS is open until 21 April 2033. The notice is a corrigendum of the original notice 23-54605, modifying the consultation address.
Risks
Inconsistency between structured data (isEuFunded=true) and XML notice (no-eu-funds). This may affect contract conditio...
Essential details such as exact eligibility criteria, award criteria, and required documents are missing, increasing bi...
Restricted procedure — pre-qualification required
No procurement documents available
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- DPS admission based on economic, financial, and professional capacity (article 7.2 of RC)
- No limit on the number of candidates admitted
- Admission decision within 10 working days (15 if additional information requested)
Requirements may be incomplete.
Buyer
Name
Location
LYON, FRA
Website
Buyer profile
Identifier
130 002 223 00043
Activity
Health
Lots (1)
LOT-0001
Supply of medical devices for parenteral access
Supply of medical devices for parenteral access (infusion supplies, syringes, catheters, needles, etc.) for UniHA member establishments. This lot covers the entire scope of the DPS.
EUR 426.6M
Estimated value
Location
Duration
Category
Deadline
Award details
UniHA_Fourniture de dispositifs médicaux de l’abord parentéral – PAR24 - M_2917
Additional CPV codes
Value note
Show original TED data
Original lot title
UniHA_Fourniture de dispositifs médicaux de l’abord parentéral – PAR24 - M_2917
Original TED description
UniHA_Fourniture de dispositifs médicaux de l’abord parentéral – PAR24 - M_2917
Procurement Details
- Publication date
- 18 Jun 2026
- Languages
- French
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 422555-2026
Documents (1)
Similar tenders
Czechia – Pharmaceutical products – Léčivý přípravek ATC skupiny S01BA01 s účinnou látkou DEXAMETHASON
Romania – Various medicinal products – Achizitie „Medicamente eliberate pe bază de reţete compensate, gratuite sau necompensate” la unităţile din cadrul D.G.A.S.P.C. Alba
Portugal – Pharmaceutical products – LM 179/2026 - Aquisição de medicamentos, produtos de apoio, suplementos alimentares, produtos de higiene e cosmética, para venda aos utentes, através dos Pontos de Dispensa de Medicamentos do Laboratório Nacional do Medicamento
Poland – Pharmaceutical products – Dostawa leku do badania klinicznego (Tirzepatyd)
Czechia – Pharmaceutical products – Léčivý přípravek ATC skupiny R03DX10 s účinnou látkou BENRALIZUMAB
Poland – Pharmaceutical products – Sukcesywna dostawa leków w ramach programu lekowego - leczenie choroby Fabryego.
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
35 / 100
Risk factors
Inconsistency between structured data (isEuFunded=true) and XML notice (no-eu-funds). This may affect contract conditio...
Essential details such as exact eligibility criteria, award criteria, and required documents are missing, increasing bi...
Restricted procedure — pre-qualification required
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications